Measurement properties of patient-reported outcome measures (PROMs) in hyperhidrosis: a systematic review.
Hyperhidrosis
Measurement properties
Patient-reported outcome measures
Reliability
Responsiveness
Validity
Journal
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
accepted:
19
07
2021
pubmed:
31
7
2021
medline:
17
3
2022
entrez:
30
7
2021
Statut:
ppublish
Résumé
To critically appraise, compare and summarize the quality of all existing PROMs that have been validated in hyperhidrosis to at least some extend by applying the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodology. Thereby, we aim to give a recommendation for the use of PROMs in future clinical trials in hyperhidrosis. We considered studies evaluating, describing or comparing measurement properties of PROMs as eligible. A systematic literature search in three big databases (MEDLINE, EMBASE and Web of Science) was performed. We assessed the methodological quality of each included study using the COSMIN Risk of Bias checklist. Furthermore, we applied predefined quality criteria for good measurement properties and finally, graded the quality of the evidence. Twenty-four articles reporting on 13 patient-reported outcome measures were included. Three instruments can be further recommended for use. They showed evidence for sufficient content validity and moderate- to high-quality evidence for sufficient internal consistency. The methodological assessment showed existing evidence gaps for eight other PROMs, which therefore require further validation studies to make an adequate decision on their recommendation. The Hyperhidrosis Disease Severity Measure-Axillary (HDSM-Ax) and the short-form health survey with 36 items (SF-36) were the only questionnaires not recommended for use in patients with hyperhidrosis due to moderate- to high-quality evidence for insufficient measurement properties. Three PROMs, the Hyperhidrosis Quality of Life Index (HidroQoL), the Hyperhidrosis Questionnaire (HQ) and the Sweating Cognitions Inventory (SCI), can be recommended for use in future clinical trials in hyperhidrosis. Results obtained with these three instruments can be seen as trustworthy. Nevertheless, further validation of all three PROMs is desirable. PROSPERO CRD42020170247.
Identifiants
pubmed: 34327635
doi: 10.1007/s11136-021-02958-3
pii: 10.1007/s11136-021-02958-3
pmc: PMC8921123
doi:
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
671-686Informations de copyright
© 2021. The Author(s).
Références
Ir J Med Sci. 2020 Aug;189(3):1023-1026
pubmed: 31898163
Health Qual Life Outcomes. 2017 Jun 8;15(1):121
pubmed: 28595584
Qual Life Res. 1999 Dec;8(8):693-8
pubmed: 10855343
Isr J Psychiatry Relat Sci. 2000;37(1):25-31
pubmed: 10857268
Br J Surg. 2006 May;93(5):582-6
pubmed: 16607680
J Drugs Dermatol. 2018 Jul 1;17(7):707-714
pubmed: 30005091
Br J Dermatol. 2021 Mar;184(3):473-481
pubmed: 32510573
Qual Life Res. 2015 Apr;24(4):1017-27
pubmed: 25367139
J Dermatolog Treat. 2019 May;30(3):303-308
pubmed: 30051732
J Eval Clin Pract. 2006 Oct;12(5):559-68
pubmed: 16987118
J Drugs Dermatol. 2021 Apr 1;20(4):410-418
pubmed: 33852243
Acta Dermatovenerol Croat. 2011;19(1):16-20
pubmed: 21489361
Eur J Neurol. 2001 May;8(3):247-52
pubmed: 11328333
J Clin Epidemiol. 2010 Jul;63(7):737-45
pubmed: 20494804
Clin Ther. 2003 Jan;25(1):298-308
pubmed: 12637128
Health Serv Insights. 2013 Aug 04;6:61-8
pubmed: 25114561
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Zentralbl Chir. 2019 Apr;144(2):139-145
pubmed: 30795027
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Qual Life Res. 2009 Oct;18(8):1115-23
pubmed: 19711195
Dermatology. 2006;212(4):343-53
pubmed: 16707884
J Psychosom Res. 2010 Jun;68(6):591-602
pubmed: 20488277
J Nurs Res. 2004 Mar;12(1):21-30
pubmed: 15136960
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Clin Auton Res. 2009 Jun;19(3):175-81
pubmed: 19370373
Dermatol Surg. 2005 Nov;31(11 Pt 1):1434-9
pubmed: 16416613
J Med Libr Assoc. 2016 Jul;104(3):240-3
pubmed: 27366130
Eur J Cardiothorac Surg. 2018 Nov 1;54(5):904-911
pubmed: 29860276
J Am Acad Dermatol. 2004 Aug;51(2):241-8
pubmed: 15280843
Syst Rev. 2016 Feb 09;5:25
pubmed: 26860189
Soc Sci Med. 2005 Feb;60(4):833-43
pubmed: 15571900
Syst Rev. 2021 Jun 2;10(1):163
pubmed: 34078465
Rev Assoc Med Bras (1992). 2016 Dec;62(9):843-847
pubmed: 28001258
Ann Thorac Surg. 2009 Jan;87(1):267-74; discussion 274-5
pubmed: 19101310
Arch Dermatol Res. 2016 Dec;308(10):743-749
pubmed: 27744497
J Patient Rep Outcomes. 2019 Sep 5;3(1):59
pubmed: 31486951
Qual Life Res. 2018 May;27(5):1159-1170
pubmed: 29550964
Biomed Res Int. 2019 Oct 31;2019:3232015
pubmed: 31781610
Thorac Surg Clin. 2016 Nov;26(4):435-443
pubmed: 27692202
Qual Life Res. 2018 May;27(5):1171-1179
pubmed: 29260445
Syst Rev. 2021 Jan 26;10(1):39
pubmed: 33499930
Qual Life Res. 2018 May;27(5):1147-1157
pubmed: 29435801
Surgeon. 2010 Oct;8(5):287-92
pubmed: 20709287